CompoAtlas

Vegan Omegas + CoQ10

Natural health product licensed in Canada

Licence holder
Advanced Orthomolecular Research Inc.
NPN or DIN-HM
80062461
Status
Active licence
Licence date
3 July 2015
Revision date
Not provided
Form
Capsule, molle
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Schizochytrium spp.

Source : En entier

Potency : 0 270-360 mg Docosahexaenoic acid

900 mgNot calculated
Schizochytrium spp.

Source : En entier

Potency : 0 135-270 mg Eicosapentaenoic acid

Not specifiedNot calculated
Schizochytrium spp.

Source : En entier

Potency : 0 450-540 mg EPA+DHA

Not specifiedNot calculated
2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl

Source : Coenzyme Q10

100 mgNot calculated

Non-medicinal ingredients

Huile de tournesol, Esters d'acide gras de saccharose, Lécithine, Amidon de maïs, Poly(sorbate) 20, Cellulose microcristalline, Laurate de saccharose, Glycérine, Fécule de pomme de terre, Béhénate de glycéryle, Extrait de romarin, Cire d'abeille, Caramel, Dioxyde de silicium, Carraghénine, Gélatine, Huile de lin, Palmitate d'ascorbyle, Sodium complexe de cuivre chlorophylline, Hypromellose, Stéaryl fumarate de sodium, Tocophérols, Esters d'acide gras de poly(glycérol), Chlorophylle, Mono- et di- glycérides, NA, Huile de carthame, Lysolécithine, Lécithine partiellement hydrolysées

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Capsuleminimum: 1 day ; maximum: 3 days
AdultesNot specified1 Capsuleminimum: 2 days ; maximum: 3 days

Uses authorised in Canada

Source of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) for the maintenance of good health. Helps support/maintain eye health/function. Helps support/maintain visual health/function. Helps support/maintain normal brain function. Helps support/maintain (normal) heart/ cardiovascular health/function. Helps to reduce the frequency of migraine headaches and associated nausea and vomiting when taken as a prophylactic. An antioxidant for the maintenance of good health.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80062461

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line